New boss brings diagnostic edge to PEB

New boss brings diagnostic edge to PEB
Peter Meintjes has experience in the global molecular diagnostics sectors relevant to Pacific Edge’s Cxbladder products. (Image: Supplied)
Dan Brunskill
Pacific Edge has appointed a molecular diagnostics expert to lead the cancer diagnostics company after the retirement of long-serving chief executive David Darling.The new CEO, Peter Meintjes, has a PhD in biological sciences from Auckland University and has been chief commercial officer of US-based organ transplant testing company Eurofins Transplant Genomics.Prior to that he served as chief executive of Hungary-based Omixon, another global molecular diagnostics company focused on organ and recipient compatibility testing.Pacific Edge said whi...

More Markets

NZ sharemarket steady despite US slump
Markets Market Close

NZ sharemarket steady despite US slump

Financial adviser says investors holding their breath for reporting season.

Tom Raynel 06 Aug 2025
ASB's $35.5m mystery payout to customers
Markets

ASB's $35.5m mystery payout to customers

CBA reveals A$33m remediation provision for ASB customers ahead of A$10b expected result.

Garth Bray 06 Aug 2025
Strong lead from US carries NZX 50 up 1.5%
Markets Market Close

Strong lead from US carries NZX 50 up 1.5%

"Bad news is good news," one analyst said.

Gregor Thompson 05 Aug 2025